These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 13106122)

  • 1. [Supposed mutagenic action of carcinogenic substances].
    POLETTINI B; NARPOZZI A
    Boll Soc Ital Biol Sper; 1953 May; 29(5):1064-6. PubMed ID: 13106122
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
    Butterworth BE
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental contributions on the problem of endogenous carcinogenic substances].
    GORACZ I
    Orv Hetil; 1953 Apr; 94(15):415-7. PubMed ID: 13063979
    [No Abstract]   [Full Text] [Related]  

  • 5. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Criteria, rules and procedures adopted by IARC in evaluating risks from different carcinogenic agents for humans].
    IARC
    Vopr Onkol; 2007; 53(6):621-41. PubMed ID: 18416130
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in expression of imprinted genes following treatment of human cancer cell lines with non-mutagenic or mutagenic carcinogens.
    Shibui T; Higo Y; Tsutsui TW; Uchida M; Oshimura M; Barrett JC; Tsutsui T
    Int J Oncol; 2008 Aug; 33(2):351-60. PubMed ID: 18636156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SENSITIVITY OF NORMAL AND NEOPLASTIC CELLS TO THE DAMAGING ACTION OF CARCINOGENIC SUBSTANCES: A REVIEW.
    VASILIEV JM; GUELSTEIN VI
    J Natl Cancer Inst; 1963 Nov; 31():1123-51. PubMed ID: 14071825
    [No Abstract]   [Full Text] [Related]  

  • 9. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
    McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
    Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on the carcinogenic and growth-inhibitory activity of lactones and related substances.
    DICKENS F; JONES HE
    Br J Cancer; 1963 Mar; 17(1):100-8. PubMed ID: 14027702
    [No Abstract]   [Full Text] [Related]  

  • 11. [Examination of the smoked products for carcinogenic effect].
    SCHMAHL D; REITER A
    Z Krebsforsch; 1953; 59(4):396-401. PubMed ID: 13137305
    [No Abstract]   [Full Text] [Related]  

  • 12. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The explanation of quantum hit theory of the relations between dosage and effect in drugs and its application to the carcinogenic effect of 4-dimethylaminoazobenzene].
    DRUCKREY H
    Strahlentherapie; 1954; 94(1):45-59. PubMed ID: 13195914
    [No Abstract]   [Full Text] [Related]  

  • 14. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk.
    Rietjens IM; Boersma MG; van der Woude H; Jeurissen SM; Schutte ME; Alink GM
    Mutat Res; 2005 Jul; 574(1-2):124-38. PubMed ID: 15914212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenic activity of a series of reactive lactones and related substances.
    DICKENS F; JONES HE
    Br J Cancer; 1961 Mar; 15(1):85-100. PubMed ID: 13722681
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiments on the mechanism of action of carcinogenic hydrocarbons. V. Experimental studies on the problem of action of carcinogenic hydrocarbons in the sense of a general tumor disposition].
    GRAFFI A; REISSIG G
    Arch Geschwulstforsch; 1957; 10(2):146-55. PubMed ID: 13445091
    [No Abstract]   [Full Text] [Related]  

  • 17. CARCINOGENIC PROPERTIES OF NUTS FROM CYCAS CIRCINALIS L. INDIGENOUS TO GUAM.
    LAQUEUR GL; MICKELSEN O; WHITING MG; KURLAND LT
    J Natl Cancer Inst; 1963 Oct; 31():919-51. PubMed ID: 14069834
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental research on the existence of an anti-carcinogenic action of the blood of cancerous subjects treated with radiotherapy].
    BELLUCCI
    Radiol Med; 1952 Jun; 38(6):569. PubMed ID: 14949366
    [No Abstract]   [Full Text] [Related]  

  • 19. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
    O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
    Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficiency of the prediction of carcinogenic activities of chemical substances based on scoring somatic mutations in the soybean Glycine max (L.) Merrill].
    Bittueva MM; Abilev SK; Tarasov VA
    Genetika; 2007 Jan; 43(1):78-87. PubMed ID: 17333942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.